Comments on: AstraZeneca acquires Dogma Therapeutics’ PCSK9 inhibitor programme /news/astrazeneca-dogma-deal/ The leading site for news and procurement in the pharmaceutical industry Thu, 01 Oct 2020 05:44:48 +0000 hourly 1 https://wordpress.org/?v=6.6.1